Evidence map›Paper›PMID 32678947›Full record

ArticleJournal of leukocyte biology2021

Classically activated mouse macrophages produce methylglyoxal that induces a TLR4- and RAGE-independent proinflammatory response.

Daniel Prantner, Shreeram Nallar, Katharina Richard, David Spiegel, Kim D Collins, Stefanie N Vogel

Open access · greenAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Avoidance of MAIT cells is an essential determinant ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Host methylglyoxal activates theProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Daniel PrantnerDepartment of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, Maryland, USA.
Shreeram NallarDepartment of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, Maryland, USA.
Katharina RichardDepartment of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, Maryland, USA.
David SpiegelDepartment of Chemistry, Yale University, New Haven, Connecticut, USA.
Kim D CollinsDepartment of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, Maryland, USA.
Stefanie N VogelDepartment of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, Maryland, USA.
University of Maryland, Baltimore · USYale University · US

Funding

Targeting TLR Signaling Pathways to Blunt Pathogen-mediated Acute Lung InjuryR01AI125215 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BLANCO, JORGE C, VOGEL, STEFANIE N. · 2017 to 2021
$2.7M
Macrophage differentiation and disease outcome in influenza infectionR01AI123371 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI VOGEL, STEFANIE N. · 2017 to 2021
$2.7M
Analysis of Cellular Metabolism using Seahhorse TechnologyS10OD025101 · OD · UNIVERSITY OF MARYLAND BALTIMORE · PI VOGEL, STEFANIE N. · 2019 to 2019
$205k
NIAID NIH HHS R01 AI123371NIAID NIH HHS R01 AI125215NIH HHS S10 OD025101
6 · The paper itself

Abstract

The highly reactive compound methylglyoxal (MG) can cause direct damage to cells and tissues by reacting with cellular macromolecules. MG has been identified as a biomarker associated with increased sepsis-induced mortality. Patients undergoing septic shock have significantly elevated circulating MG levels compared to postoperative patients and healthy controls. Furthermore, MG has been implicated in the development of type II diabetes mellitus and Alzheimer's disease. Because MG is generated during glycolysis, we hypothesized that MG may be produced by classically activated (M1) macrophages, possibly contributing to the inflammatory response. LPS and IFN-γ-treated macrophages acquired an M1 phenotype (as evidenced by M1 markers and enhanced glycolysis) and formed MG adducts, MG-H1, MG-H2, and MG-H3, which were detected using antibodies specific for MG-modified proteins (methylglyoxal 5-hydro-5-methylimidazolones). MG adducts were also increased in the lungs of LPS-treated mice. Macrophages treated with LPS and IFN-γ also exhibited decreased expression of glyoxalase 1 (Glo1), an enzyme that metabolizes MG. Concentrations of exogenous, purified MG > 0.5 mM were toxic to macrophages; however, a nontoxic dose of 0.3 mM induced TNF-α and IL-1β, albeit to a lesser extent than LPS stimulation. Despite prior evidence that MG adducts may signal through "receptor for advanced glycation endproducts" (RAGE), MG-mediated cell death and cytokine induction by exogenous MG was RAGE-independent in primary macrophages. Finally, RAGE-deficient mice did not exhibit a significant survival advantage following lethal LPS injection. Overall, our evidence suggests that MG may be produced by M1 macrophages during sepsis, following IFN-γ-dependent down-regulation of Glo1, contributing to over-exuberant inflammation.

Indexed as

Macrophage ActivationAerobiosisAnimalsCell DeathCell PolarityCells, CulturedFemaleGlycolysisGuanidinesInflammationInterferon-gammaLactoylglutathione LyaseLungMacrophagesMaleMiceGuanidinesInterferon-gammaLactoylglutathione LyaseNfe2l2 protein, mouseNF-E2-Related Factor 2pimagedinePyruvaldehydeReceptor for Advanced Glycation End ProductsRNA, MessengerSerum Albumin, BovineToll-Like Receptor 4cytokine regulationinflammationinnate immunitymetabolism

Identifiers

PMID32678947
PMCPMC7855181
OpenAlexW3042762059

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.